Galiximab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric (primate/human) |
Target | CD80 |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 357613-77-5 |
ChemSpider | none |
UNII | S9OX9692ZB |
KEGG | D04295 |
(what is this?) (verify) |
Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, it is undergoing Phase III clinical trials.[1] The drug is a chimeric antibody from Macaca irus and Homo sapiens.[2]
References
External links
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.